evomela.com valuation and analysis
Robots.txt Information
| Robot | Path | Permission |
| GoogleBot | / | ✔ |
| BingBot | / | ✔ |
| BaiduSpider | / | ✔ |
| YandexBot | / | ✔ |
# START YOAST BLOCK # --------------------------- User-agent: * Disallow: Sitemap: https://evomela.com/sitemap_index.xml # --------------------------- # END YOAST | ||
Meta Tags
| Title | EVOMELA (melphalan) for a type of cancer called multiple |
| Description | EVOMELA® Prescribing Information Important Safety Information EVOMELA Home EVOMELA Stability EVOMELA Bioequivalence EVOMELA Efficacy and Safety Study Design Common |
| Keywords | N/A |
Server Information
| WebSite | |
| Host IP | 74.220.203.200 |
| Location | United States |
Related Websites
| Site | Rank |
More to Explore
evomela.com Valuation
|
US$3,077,557
Last updated: 2023-05-16 22:02:02
evomela.com has Semrush global rank of 3,439,190. evomela.com has an estimated worth of US$ 3,077,557, based on its estimated Ads revenue. evomela.com receives approximately 355,103 unique visitors each day. Its web server is located in United States, with IP address 74.220.203.200. According to SiteAdvisor, evomela.com is safe to visit. |
Traffic & Worth Estimates
| Purchase/Sale Value | US$3,077,557 |
| Daily Ads Revenue | US$2,841 |
| Monthly Ads Revenue | US$85,225 |
| Yearly Ads Revenue | US$1,022,696 |
| Daily Unique Visitors | 23,674 |
| Note: All traffic and earnings values are estimates. | |
DNS Records
| Host | Type | TTL | Data |
| evomela.com. | A | 14400 | IP: 74.220.203.200 |
| evomela.com. | NS | 21600 | NS Record: ns1.hostmonster.com. |
| evomela.com. | NS | 21600 | NS Record: ns2.hostmonster.com. |
| evomela.com. | MX | 14400 | MX Record: 0 mail.evomela.com. |
| evomela.com. | TXT | 14400 | TXT Record: v=spf1 +a +mx +ip4:67.20.116.98 +ip4:74.220.203.200 +include:hostmonster.com ~all |
HtmlToTextCheckTime:2023-05-16 22:02:02
| Prescribing Information Important Safety Information EVOMELA Home EVOMELA Stability EVOMELA Bioequivalence EVOMELA Efficacy and Safety Study Design Common Adverse Reactions Patient Information Contact Us --> This site is intended for US audiences only. EVOMELA ® Stable by design. Indications and Usage Evomela is indicated for use as a high-dose conditioning treatment prior to hematopoietic progenitor (stem) cell transplantation in patients with multiple myeloma. LEARN MORE WARNING: SEVERE BONE MARROW SUPPRESSION, HYPERSENSITIVITY, AND LEUKEMOGENICITY Severe bone marrow suppression with resulting infection or bleeding may occur. Controlled trials comparing intravenous (IV) melphalan to oral melphalan have shown more myelosuppression with the IV formulation. Monitor hematologic laboratory parameters. Hypersensitivity reactions, including anaphylaxis, have occurred in approximately 2% of patients who received the IV formulation of melphalan. Discontinue treatment with EVOMELA for |
evomela.com Whois Information
Domain Name: EVOMELA.COM Registry Domain ID: 1862342765_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.fastdomain.com Registrar URL: http://www.fastdomain.com Updated Date: 2019-08-06T04:27:30Z Creation Date: 2014-06-10T20:44:18Z Registry Expiry Date: 2022-06-10T20:44:18Z Registrar: FastDomain Inc. Registrar IANA ID: 1154 Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited Name Server: NS1.HOSTMONSTER.COM Name Server: NS2.HOSTMONSTER.COM DNSSEC: unsigned >>> Last update of whois database: 2022-02-19T07:06:25Z <<< |